By indication / Renal cell carcinoma
Renal cell carcinoma
4 imaging agents and 4 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [18F]AlF-NOTA-FAPI-04 | F-18 | — | 7 |
| [11C]SSI-4 | C-11 | preclinical | 1 |
| [68Ga]Ga-P16-093 | Ga-68 | Phase 2 clinical trial | 1 |
| [18F]VM4-037 | F-18 | Research |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [153Sm]Sm-EDTMP | Sm-153 | approved | 10 |
| [18F]AlF-LNC1007 | F-18 | Reported once | 2 |
| [177Lu]Lu-DOTA-hG250 | Lu-177 | Reported once | 1 |
| [225Ac]Ac(MacropaSq-hG250) | Ac-225 | preclinical study | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch